Abstract
Background and objectives Cognitive symptoms persisting beyond 3 months following COVID-19 present a considerable disease burden. We aimed to establish a domain-specific cognitive profile of post-COVID syndrome, and relationships with clinical variables, to provide relevant information for outcome prediction and treatment decision-making.
Methods We compared cognitive performance on the Oxford Cognitive Screen-Plus between a large post-COVID cohort (n = 282) and a socio-demographically matched healthy control group (n = 52). We assessed task- and domain-level dysfunction and relationships between clinical and patient-reported outcomes.
Results Patients scored significantly lower on delayed verbal memory, attention, and executive functioning than healthy controls and in each of these domains, 10-20% of patients scored below cutoff. Delayed Memory was particularly affected and a rather small proportion of its variace was explained by hospitalization (β = -.67, p < .01) and age (β = -.03, p < .01; R2adj. = .06). Hospitalization further predicted attention performance (β = -.83, p < .001; R2adj. = .04).
Interpretation Post-COVID syndrome is associated with long-term cognitive dysfunction, particularly in delayed verbal memory, attention, and executive functioning, relatively independent of original disease severity. Next, longitudinal investigation of the domain-dysfunctions in this cohort is needed to examine their trajectory.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The post-COVID Center was supported by the Thueringer Aufbaubank (2021 FGI 0060).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the Friedrich-Schiller-University gave ethical approval for this study [amendment to 5082-02/17].
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵2 shared senior authorship
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
